🇺🇸 FDA
Pipeline program

Nanosensor

22-019820

Phase 1 other active

Quick answer

Nanosensor for MItochondrial Myopathies is a Phase 1 program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
MItochondrial Myopathies
Phase
Phase 1
Modality
other
Status
active

Clinical trials